Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Attwill Medical Solutions is a commercial-stage CDMO with America’s largest lyophilization capacity, providing development and contract manufacturing for pharmaceuticals, medical devices, and biologics. Attwill has partnerships for the clinical development and commercial manufacturing of novel therapeutics, including lyophilized formulations (e.g., for Revive Therapeutics' bucillamine). The company is involved in the scale-up and GMP production of sterile pharmaceuticals, active pharmaceutical ingredients, and advanced medical devices, including FDA-cleared (510(k)) products. Specific current clinical results are typically reported by Attwill’s partners; Attwill enables their manufacture and scale-up[1][5][7].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Attwill Medical Solutions.